Under way, not recruiting
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
NCT07120945 · Medtronic - MITG · Updated 2 June 2026
- What is being tested
- Robotic Assisted-Surgery (RAS) Hysterectomy
- For
- Uterine Fibroids (UF); Menstrual Disorders; Adenomyosis of Uterus; Endometriosis; Uterine Prolapse; Precancerous/Nonmalignant Condition; Cervical Cancer; Endometrial Cancer; Ovarian Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years and older. About 70 people. The full rules are on the registry page.
- Where
- United States (5 sites)
- When
- Starts or started 28 Aug 2025, ends May 2031. Registered 13 Aug 2025.
- Results
- None posted yet.
In the researchers' words
The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.
Sites
- Ascension St. Vincent's RiversideJacksonville, Florida, United States
- The University of South FloridaTampa, Florida, United States
- Duke UniversityDurham, North Carolina, United States
- Allegheny Health Network - West PennPittsburgh, Pennsylvania, United States
- Swedish Medical CenterSeattle, Washington, United States